Menu
Not yet recruiting NCT07027176

Effects of Walking Exercise on Sleep Quality in Older Adults

No phase Interventional Sleep Quality Cognitive Function

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: walking exercise.
Who it may be relevant to
Registry conditions: Sleep Quality, Cognitive Function. Basic parameters: 60 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of Walking Exercise on Sleep Quality, Memory, and Attention in Older Adults With Poor Sleep Quality

Overview

This study aims to explore whether increasing physical activity can improve sleep quality in older adults, particularly those with poor sleep, and whether such improvements positively influence cognitive functions such as memory and attention. The goal is to provide a practical intervention strategy to enhance both sleep quality and cognitive function, contributing to healthy aging.

Interventions

  • Behavioral walking exercise
    Divided into low-intensity and moderate-intensity exercise intervention groups, participants exercised either during the day or at night. The intervention lasted for 12 weeks.

Primary outcome measures

  • Chinese version of the Pittsburgh Sleep Quality Index [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Digital Span Test [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Chinese version Verbal Learning Test [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Chinese Version Trail Making Test [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Chinese version of Stroop Color and Word test [Time frame: From pre-intervention to the end of intervention at 12 weeks]
Secondary outcome measures (5)
  • Montreal Cognitive Assessment [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Six-Minute Walk Test [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Multidimensional Fatigue Inventory [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Depression Anxiety Stress Scales-21 [Time frame: From pre-intervention to the end of intervention at 12 weeks]
  • Heart rate variability [Time frame: From pre-intervention to the end of intervention at 12 weeks]

Eligibility criteria

Inclusion criteria

  • Age between 60 and 80
  • Montreal Cognitive Assessment score > 26
  • Pittsburgh Sleep Quality Index score > 5
  • Not participated in any regular exercise program in the past 3 months
  • Being able to understand and follow the exercise program

Exclusion criteria

  • Suffering from any neurological or musculoskeletal disorders
  • Visual problems
  • Geriatric Depression Scale score ≥ 6
  • Vestibular disease or vestibular dysfunction
  • Being unable to walk independently due to neuromuscular or musculoskeletal limitations
  • A history of mental illness
  • Untreated obstructive sleep apnea
  • A history of electroconvulsive therapy or severe head injury leading to prolonged unconsciousness
  • A history of alcoholism or dependence within the past 2 years
  • A history of cancer within the past 5 years
  • Any major systemic diseases, unstable medical conditions (such as insulin-dependent diabetes or uncontrolled diabetes, uncontrolled hypertension (systolic pressure > 170 or diastolic pressure > 100 mmHg)),
  • Taking medications that affect the central nervous system, balance, coordination, or sleep (such as antidepressants, vestibular sedatives or anxiolytics, sleep aids)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Taiwan · 1 center
  • Department of Physical Therapy and Assistive Technology — Taipei

Identifiers

NCT: NCT07027176 · NYCU114071AF

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗